FOR THE NEXT GENERATION OF PHYSICIANS
← All USMLE guides
HEMATOLOGY AND ONCOLOGY

Tumor markers, oncogenes and tumor suppressor genes.

Which tumor marker goes with which cancer, key oncogenes (RAS, MYC, HER2) and tumor suppressors (p53, RB, APC).

Tumor markers monitor disease, not screen for it. Oncogene and suppressor pairs are a common recall list.

Markers

  • Alpha-fetoprotein: hepatocellular carcinoma and yolk sac tumor.
  • CA-125: ovarian cancer.
  • CA 19-9: pancreatic cancer.
  • CEA: colorectal cancer.
  • PSA: prostate cancer.
  • Beta-hCG: choriocarcinoma, hydatidiform mole and germ cell tumors.
  • Calcitonin: medullary thyroid carcinoma.
  • S-100: melanoma and neural tumors.

Genes

RAS (colorectal, pancreatic), HER2/neu (breast, trastuzumab), MYC (Burkitt), BCR-ABL (CML), RET (MEN2), ALK (lung). Tumor suppressors: p53 (Li-Fraumeni), RB (retinoblastoma, E2F control), APC (FAP), BRCA1 and BRCA2, NF1 and NF2, VHL.

Principle

Oncogenes need one activating hit; suppressors need two (Knudson hypothesis).

Keep going in hematology and oncology

Related on USMLE WEB

Frequently asked questions

What is CA-125 used to follow?

Ovarian cancer.

Which gene is mutated in Li-Fraumeni syndrome?

TP53.